TORU UMEHARA

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The prognosis of leptomeningeal dissemination of recurrent glioblastoma is poor, and chemotherapy results in minimal palliative efficacy. Temozolomide (TMZ) is an established therapy for patients with malignant glioma and the standard of care in parenchymal gliomas; however, few reports have been published with regard to its use for the treatment of(More)
  • 1